All the funding deals in the MedTech market
Last updated: 13 July 2026
In our updated market reports, you will find everything you need
The MedTech market attracts funding across medical devices, diagnostic systems, surgical tools, connected healthcare products, and implantable technologies.
We conducted deep research and collected 112 MedTech market funding deals announced between 2024 and Q3 2026.
We refresh this MedTech market funding page very often to include newly announced deals.
Summary table of the funding deals for the MedTech market since 2024
We define the MedTech market as medical devices, digital tools, and clinical equipment used to diagnose, monitor, or treat patients.
It includes Medical Devices, Diagnostic Devices, Surgical Tools, Connected Medical Devices, Hospital Equipment, and Implantable Devices.
It excludes broader adjacent markets unless the product is built specifically for this use case.
We focused exclusively on pure players, defined as companies with at least 70–80% of their business directly tied to the MedTech market.
Our analysis has been done at a global level with a minimum funding threshold of $300k.
If you want a longer-term view, we also have a study of how funding activity in the MedTech market has changed over the years.
| Name | What they do | Amount in $ | Quarter | Source(s) |
|---|---|---|---|---|
| Sidekick Health | Develops digital treatments and software for managing chronic diseases. | $20.0M | Q3 2026 | Pharmaphorum |
| Intu Diagnostics | Develops a portable molecular diagnostic platform that works without a laboratory. | $1.2M | Q2 2026 | EU-Startups |
| Icarus Medical | Creates customized orthopedic braces that improve joint stability and movement. | $7.2M | Q2 2026 | FinSMEs |
| CroíValve | Develops a catheter-delivered implant for severe tricuspid valve leakage. | $20.0M | Q2 2026 | CroíValve |
| Rivermark Medical | Develops a minimally invasive device for treating an enlarged prostate. | $20.0M | Q2 2026 | Andera Partners |
| Urologic Health | Develops non-invasive technology for measuring and monitoring bladder function. | $11.0M | Q2 2026 | PR Newswire |
| GT Medical Technologies | Commercializes implantable radiation treatments for patients with operable brain tumors. | $100.0M | Q2 2026 | PR Newswire |
| CereVasc | Develops a minimally invasive shunt system for treating normal-pressure hydrocephalus. | $85.0M | Q2 2026 | CereVasc |
| Subtle Medical | Uses artificial intelligence to improve medical imaging speed, quality, and efficiency. | $33.0M | Q2 2026 | Medical Device Network |
| Vortex Imaging | Develops computational ultrasound systems that produce clearer diagnostic images. | $12.0M | Q2 2026 | FinSMEs |
| Butterfly Medical | Develops a non-surgical device for treating an enlarged prostate. | $21.0M | Q2 2026 | PR Newswire |
| UroMems | Develops an active implant for treating stress urinary incontinence. | $60.0M | Q2 2026 | FinSMEs |
| PlaqueTec | Develops intracoronary testing technology that identifies cardiovascular inflammation. | $5.0M | Q2 2026 | FinSMEs |
| Deep Blue Medical | Develops surgical devices for stronger and more reliable soft-tissue repair. | $5.6M | Q2 2026 | FinSMEs |
| AcuityMD | Provides AI-powered market and procedure data to medical-device sales teams. | $80.0M | Q2 2026 | Business Wire |
| AI Diagnostics | Develops an AI-enabled digital stethoscope for early tuberculosis screening. | $4.5M | Q2 2026 | Business Explainer |
| Sonire Therapeutics | Develops focused ultrasound therapy for treating pancreatic cancer. | $18.0M | Q2 2026 | PR Newswire |
| Click Therapeutics | Develops prescription software treatments for neurological and psychiatric conditions. | $50.0M | Q2 2026 | Built In NYC |
| Endovascular Engineering (E2) | Develops mechanical thrombectomy technology for removing dangerous blood clots. | $80.0M | Q2 2026 | MedTech Dive |
| neuroClues | Uses eye-movement measurements to identify neurological disorders earlier. | $10.8M | Q2 2026 | EU-Startups |
| MedScout | Provides AI-powered commercial intelligence for medical-device and diagnostics companies. | $10.0M | Q1 2026 | Intelligence360 |
| Combat Medical | Develops heated chemotherapy systems for treating cancers inside body cavities. | $3.3M | Q1 2026 | FinSMEs |
| XCath | Develops robotic systems for remotely assisted neurovascular procedures. | $30.0M | Q1 2026 | Venture Capital Access Online |
| Cognito Therapeutics | Develops non-invasive light and sound therapy for Alzheimer’s disease. | $105.0M | Q1 2026 | MedTech Dive |
| Science Corporation | Develops a retinal brain-computer implant designed to restore vision. | $230.0M | Q1 2026 | MedTech Dive |
| Avisi Technologies | Develops an eye implant that lowers pressure in glaucoma patients. | $10.7M | Q1 2026 | PR Newswire |
| Flinn.ai | Automates regulatory and quality workflows for medical-technology companies. | $20.0M | Q1 2026 | FinSMEs |
| Synchrony Medical | Develops an airway-clearance system for people with respiratory conditions. | $5.0M | Q1 2026 | FinSMEs |
| Neurent Medical | Commercializes a minimally invasive device for treating chronic rhinitis. | $74.0M | Q1 2026 | PR Newswire |
| Stratus Medical | Develops radiofrequency ablation technology for treating chronic pain. | $10.0M | Q1 2026 | PR Newswire |
| Flywheel | Provides medical-imaging data systems for clinical trials and AI development. | $25.0M | Q1 2026 | PR Newswire |
| ClearCut Surgical | Develops an electrosurgery device with smoke evacuation and liquid suction. | $3.7M | Q1 2026 | ClearCut Surgical |
| MARS Bioimaging | Develops photon-counting CT scanners for research and point-of-care diagnosis. | $8.9M | Q1 2026 | Med-Tech Insights |
| Inquis Medical | Develops thrombectomy devices for treating blood clots in veins. | $75.0M | Q1 2026 | TMCnet |
| ViCentra | Develops the Kaleido wearable insulin-pump system for diabetes management. | $13.0M | Q1 2026 | FinSMEs |
| FineHeart | Develops active implantable cardiac devices for patients with heart failure. | $38.5M | Q1 2026 | FineHeart |
| BrightHeart | Develops AI software that supports prenatal ultrasound diagnosis. | $11.9M | Q1 2026 | Sofinnova Partners |
| Surgerii Robotics | Develops single-port robotic systems for minimally invasive surgery. | $100.0M | Q1 2026 | MedTech Dive |
| Spiro Medical | Develops a pulmonary neuromodulation system for treating asthma. | $67.0M | Q1 2026 | PR Newswire |
| Biobeat | Develops cuffless blood-pressure and continuous vital-sign monitoring devices. | $50.0M | Q1 2026 | MedTech Dive |
| roclub | Provides remote-operation technology for MRI and CT imaging equipment. | $11.7M | Q4 2025 | Tech Funding News |
| Petal Surgical | Develops robotic technology for incisionless surgical procedures. | $10.0M | Q4 2025 | MassDevice |
| MediView XR | Develops augmented-reality navigation and image guidance for surgery. | $24.0M | Q4 2025 | PR Newswire |
| Oath Surgical | Develops an AI-powered surgical system designed around surgeon ownership. | $24.0M | Q4 2025 | Business Wire |
| Akura Medical | Develops thrombectomy devices and planning software for blood-clot removal. | $53.0M | Q4 2025 | MedTech Dive |
| Distalmotion | Develops the Dexter robotic surgery system for outpatient procedures. | $150.0M | Q4 2025 | Distalmotion |
| TriAgenics | Develops a medical device that prevents third molars without surgery. | $3.0M | Q3 2025 | TriAgenics |
| Plexāā | Develops a medical device and app for preparing patients for breast surgery. | $4.5M | Q3 2025 | FinSMEs |
| Respiree | Provides connected monitoring for respiratory disease and hospital-to-home care. | $11.6M | Q3 2025 | ClavystBio |
| SafeHeal | Develops a colorectal surgery device that can reduce temporary ostomies. | $11.0M | Q3 2025 | EU-Startups |
| MAUI Imaging | Develops ultrasound imaging that can see through bone, gas, and implants. | $14.0M | Q3 2025 | Business Insider |
| RDS | Develops a connected patch for remote patient monitoring. | $15.1M | Q3 2025 | EU-Startups |
| Restore Medical | Develops catheter-based therapies for patients with heart failure. | $23.0M | Q3 2025 | FinSMEs |
| Method AI | Uses ultrasound and AI to guide surgical oncology procedures. | $20.0M | Q3 2025 | Business Wire |
| Versa Vascular | Develops technology for repairing the heart’s tricuspid valve. | $27.3M | Q3 2025 | S3 Ventures |
| Field Medical | Develops pulsed-field ablation technology for ventricular tachycardia. | $35.0M | Q3 2025 | MedTech Dive |
| Ketryx | Provides AI-powered quality and compliance software for medical-device development. | $39.0M | Q3 2025 | MedTech Dive |
| Luna Health | Develops an automated insulin patch pump for insulin-pen users. | $23.6M | Q3 2025 | MedTech Dive |
| ViCentra | Develops wearable insulin pumps and automated insulin-delivery technology. | $85.0M | Q3 2025 | Drug Delivery Business |
| Apreo Health | Develops an airway scaffold for patients with severe emphysema. | $130.0M | Q3 2025 | Business Wire |
| Kardium | Develops a pulsed-field ablation system for atrial fibrillation. | $250.0M | Q3 2025 | Business Wire |
| Aiatella | Develops vascular measurement software for cardiovascular imaging and aneurysm diagnosis. | $2.16M | Q2 2025 | FinSMEs |
| Acclaro Medical | Develops fiber-laser technology for medical and aesthetic treatments. | $23.0M | Q2 2025 | Accelmed |
| AMT Medical | Develops device-based bypass technology for coronary artery disease. | $25.0M | Q2 2025 | FinSMEs |
| Alpheus Medical | Develops ultrasound-based treatment for solid tumors, starting with glioblastoma. | $52.0M | Q2 2025 | PR Newswire |
| ForSight Robotics | Develops robotic systems for cataract and other eye surgeries. | $125.0M | Q2 2025 | ForSight Robotics |
| Neuralink | Develops implantable brain-computer interfaces for severe neurological conditions. | $650.0M | Q2 2025 | Neuralink |
| VQ Biomedical | Develops a catheter device for severe lung injury and respiratory distress. | $5.0M | Q1 2025 | Axios |
| Nervonik | Develops peripheral nerve stimulation for pain treatment without opioids. | $13.0M | Q1 2025 | MassDevice |
| FIZE Medical | Develops technology that improves fluid management in hospitals and procedures. | $30.0M | Q1 2025 | FinSMEs |
| Deciphex | Provides digital pathology diagnostics and clinical pathology services. | $32.2M | Q1 2025 | Axios |
| Aerin Medical | Develops devices for nasal airway obstruction and chronic rhinitis. | $32.5M | Q1 2025 | FinSMEs |
| GT Medical Technologies | Develops implantable radiation therapy for patients with brain tumors. | $37.0M | Q1 2025 | FinSMEs |
| OrganOx | Develops machines that preserve donor organs under near-normal conditions. | $142.0M | Q1 2025 | The Times |
| Fire1 | Develops implantable heart-failure monitoring and fluid-management technology. | $120.0M | Q1 2025 | Axios |
| Neko Health | Provides preventive full-body scans using proprietary imaging and sensing devices. | $260.0M | Q1 2025 | MedTech Dive |
| ShiraTronics | Develops implantable neurostimulation treatment for chronic migraine. | $66.0M | Q4 2024 | PR Newswire |
| Horizon Surgical Systems | Develops AI-enabled microsurgical robots for eye procedures. | $30.0M | Q4 2024 | Business Wire |
| Minze Health | Develops connected urology diagnostics and prescription digital treatments. | $5.3M | Q4 2024 | Business Wire |
| Endovascular Engineering | Develops thrombectomy systems for treating pulmonary embolism. | $42.0M | Q4 2024 | 415 Capital |
| Neuranics | Develops magnetic sensors for cardiac and neuromuscular diagnostics. | $0.7M | Q4 2024 | Entrackr |
| Capstan Medical | Develops surgical robots and catheter-delivered implants for structural heart treatment. | $110.0M | Q4 2024 | MassDevice |
| LaNua Medical | Develops embolization technology for controlling internal bleeding. | $6.5M | Q4 2024 | RTÉ |
| Fluid Biomed | Develops a bioabsorbable polymer stent for treating brain aneurysms. | $27.0M | Q4 2024 | Business Wire |
| Precision Neuroscience | Develops an implantable brain-computer interface for people with paralysis. | $102.0M | Q4 2024 | Yahoo Finance |
| Prenuvo | Provides AI-enabled whole-body MRI screening and imaging products. | $120.0M | Q4 2024 | Prenuvo |
| Neuspera Medical | Develops implantable sacral neuromodulation systems. | $23.0M | Q3 2024 | PR Newswire |
| HEPTA Medical | Develops minimally invasive thermal ablation for early lung cancer. | $6.2M | Q3 2024 | Pulse 2.0 |
| Novocuff | Develops a device that stabilizes the cervix to reduce premature birth. | $26.0M | Q3 2024 | MassDevice |
| Magenta Medical | Develops a miniature heart pump inserted through a catheter. | $105.0M | Q3 2024 | MassDevice |
| Kestra Medical | Develops a wearable defibrillator system for patients at cardiac risk. | $196.0M | Q3 2024 | Business Wire |
| Imperative Care | Develops interventional devices for stroke and vascular treatment. | $150.0M | Q3 2024 | Business Wire |
| 4D Medicine | Develops resorbable materials for 3D-printed medical devices. | $4.4M | Q3 2024 | TCT Magazine |
| Neptune Medical | Develops robotic and endoluminal technology for gastrointestinal surgery. | $97.0M | Q3 2024 | MassDevice |
| HistoSonics | Develops non-invasive histotripsy technology for destroying tumors. | $102.0M | Q3 2024 | G-MedTech |
| XII Medical | Develops implantable neuromodulation treatment for obstructive sleep apnea. | $45.0M | Q3 2024 | PR Newswire |
| Melodi Health | Develops medical devices for breast reconstruction after mastectomy. | $10.75M | Q3 2024 | GS MedTech |
| CSA Medical | Develops liquid nitrogen spray treatment for chronic bronchitis. | $53.0M | Q3 2024 | PR Newswire |
| SpectraWAVE | Develops intravascular imaging systems for coronary procedures. | $50.0M | Q3 2024 | Business Wire |
| Blackrock Neurotech | Develops implantable brain-computer interface technology. | $200.0M | Q2 2024 | Tether |
| Averto Medical | Develops minimally invasive gastrointestinal devices that can prevent ostomies. | $30.5M | Q2 2024 | MedTech Innovator |
| Allez Health | Develops continuous glucose-monitoring biosensor technology. | $60.0M | Q2 2024 | Business Wire |
| Amber Therapeutics | Develops implantable neuromodulation treatment for urinary incontinence. | $100.0M | Q2 2024 | EIN Presswire |
| Kardium | Develops cardiac mapping and ablation technology for atrial fibrillation. | $104.0M | Q2 2024 | Kardium |
| Insightec | Develops focused ultrasound systems for incisionless brain procedures. | $150.0M | Q2 2024 | Insightec |
| CardioMech | Develops a catheter-delivered implant for repairing the mitral valve. | $13.0M | Q1 2024 | Twin Cities Business |
| Vektor Medical | Uses AI-based ECG mapping to support heart rhythm procedures. | $16.0M | Q1 2024 | Medical Device Network |
| Acorai | Develops non-invasive pressure monitoring for patients with heart failure. | $4.5M | Q1 2024 | Acorai |
| Synergy Spine Solutions | Develops artificial cervical disc replacement devices. | $30.0M | Q1 2024 | The Spine Market Group |
| Impulse Dynamics | Develops implantable cardiac contractility devices for heart failure. | $136.0M | Q1 2024 | Impulse Dynamics |
| Mainstay Medical | Develops implantable neurostimulation treatment for chronic lower-back pain. | $125.0M | Q1 2024 | Mainstay Medical |
| Argá Medtech | Develops pulsed-field ablation technology for atrial fibrillation. | $58.3M | Q1 2024 | Argá Medtech |
Related blog posts
- The highest-valued startups in the MedTech market
- What does funding activity look like in the MedTech market?
- The most heavily funded startups in the MedTech market
- What are the key fundraising trends in the MedTech market?
